-
Jefferies Raises 'Top Pick' Abercrombie & Fitch PT To $50, Cash-Flows Have Been Put To Good Use
Tuesday, March 22, 2016 - 8:44am | 244On Tuesday, Jefferies issued a company note on Abercrombie & Fitch Co. (NYSE: ANF) after recent analysis showed improving company financials, more efficient business operations and appropriate use of cash flows that could drive business value and increase the company's bottom line....
-
Boeing Development Ahead Of Schedule
Friday, March 18, 2016 - 12:49pm | 221Jefferies recently issued a company note on Boeing Co. (NYSE: BA) after recent analysis showed several key initiatives that could drive growth in profitability. Analysts rate Boeing as a Buy with a $165 price target. Analysts Howard Rubel and Sheila Kahyaoglu wrote, "We continue to believe...
-
Data Center REIT CyrusOne Jefferies Conference - Key Takeaways
Wednesday, May 13, 2015 - 9:31am | 812On May 12, data center CyrusOne Inc (NASDAQ: CONE) CFO Kim Sheehy presented at the Jefferies 2015 Global Technology, Media and Telecom conference. CyrusOne owns and operates 27 data center facilities, containing 1.3 million SF, located in eight U.S. markets, London and Singapore. CyrusOne is...
-
Jefferies Maintains Apple at Hold on Emerging Market Price Pressures
Tuesday, April 2, 2013 - 9:36am | 125In a report published Tuesday, Jefferies analyst Peter Misek reiterated his Hold rating on Apple (NASDAQ: AAPL) stock and maintained its price target at $420. In the report, Misek wrote, "Our in-depth global analysis of smartphone markets, incomes, and ecosystem strength by country concludes that...
-
UPDATE: Jefferies Raises PT on Kohl's Corporation on Reasonable Guidance
Friday, March 1, 2013 - 10:33am | 112In a report published Friday, Jefferies reiterated its Buy rating on Kohl's Corporation (NYSE: KSS), and slightly raised its price target from $52.00 to $53.00. Jefferies noted, “KSS shares are out of favour, investor patience is thin, and until SSS come back the stock could remain cheap, sporting...
-
In-Depth Look at Opko Health's Portfolio and Prospects
Monday, March 26, 2012 - 5:53am | 1378OVERVIEW Opko Health (NYSE: OPK) is a mid-cap pharmaceutical stock with several corporate growth strategies: clinical drugs, medical devices, and strategic acquisitions. Of particular interest to many investors is its CEO's systematic buyback of common stock in the open market, totaling over $23...
-
A Peek Into The Market Before The Trading Starts
Thursday, February 16, 2012 - 8:26am | 407Pre-open movers US stock futures are lower this morning, ahead of jobless claims data. Futures for the Dow Jones Industrial Average dropped 33 points to 12,730.00 and S&P 500 index futures fell 4.70 points to 1,337.50. Nasdaq 100 futures declined 3.25 points to 2,554.25. A Peek Into Global...
-
Jefferies Reiterates Urban Outfitters Underperform, $19 PT
Monday, September 19, 2011 - 3:57pm | 92Jefferies reiterated its Urban Outfitters (NASDAQ: URBN) Underperform rating and $19 price target in a research report published today. In the report, Jefferies states, "We remain cautious around URBN shares as growth slows, returns erode and trends are not expected to snap back anytime soon. With...
-
Jefferies Comments on Wynn Resorts
Tuesday, September 13, 2011 - 9:37am | 91Jefferies provided color on Wynn Resorts (NASDAQ: WYNN) in a research report published today. Jefferies has previously given Wynn Resorts a Buy rating. In the report, Jefferies states, "Wynn Macau has reached an agreement with the Macau Government for its Cotai Land Concession Contract. We see...
-
Jefferies Comments on Forest Labs
Monday, August 1, 2011 - 3:45pm | 130Jefferies provided color on Forest Labs (NYSE: FRX) in a research report published today. Jefferies has previously given Forest Labs a Buy rating and $46 price target. In the report, Jefferies states, "We think most people have missed the fact that in its SEC filing on Friday and its letter to...
-
Jefferies Maintains Magnum Hunter Buy
Thursday, July 14, 2011 - 2:29pm | 86Jefferies maintained its Magnum Hunter (NYSE: MHR) Buy rating in a research report published today. Jefferies has previously given Magnum Hunter an $11 price target. In the report, Jefferies states, "Mid-year reserve growth shows transformative nature of acquisitions. Organic growth tracking below...
-
Jefferies Keeps Buy Rating on Lear Corp.
Monday, May 2, 2011 - 9:48am | 65Jefferies & Company kept its Buy rating on Lear Corp. (LEA) Friday after the company reported earnings. Jefferies states,"LEA upsided 1Q consensus by a resounding 28%. At 3.7x forward EBITDA, we feel the shares are simply too cheap to ignore. Reiterate Buy rating." Shares of Lear Corp. (LEA)...
-
Jefferies Maintains Hold Rating and PT of $9 on shares of Morgans Hotel Group
Monday, May 2, 2011 - 9:41am | 95Jefferies & Compnay maintained its Hold rating and Price Target of $9 on shares of Morgans Hotel Group(MHGC) Jefferies states,"We believe the execution of an asset lighter strategy with the recent sale of three owned hotels and new management contracts clearly improve the leverage profile and...
-
Jefferies Maintains its Hold Position and $80 PT on McDonald's
Monday, May 2, 2011 - 9:32am | 99Jefferies & Company maintained its Hold Position and Price Target of $80 on shares of McDonalds(MCD). Jefferies reported,"We recently spent time with investors at MCD headquarters, meeting with CFO Pete Bensen & APMEA CFO Dave Garland. We came away with increased confidence in the US...
-
Jefferies Maintains Hold Rating on Brightpoint Inc.
Monday, May 2, 2011 - 9:25am | 96Jefferies & Company has maintained its Hold rating on Brightpoint Inc. (CELL). Jefferies reports,"We expected strong revenues but margin pressures. The Touchstone acq and a mix shift from EMEA to Asia pushed GM lower but ASPs higher for both Logistics and Distribution. Overall, results and...